Clinical Trial Update: HYPGENE-Genetics Fitness Obesity & Risk of Hypertension

View source ↗

Summary

The NHLBI-funded HYPGENE trial examining genetics, fitness, obesity, and the risk of hypertension has completed its study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypertension
• Obesity

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED